Literature DB >> 8608683

Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients.

J C Mertens1, G Willemsen, J L Van Saase, J H Bolk, B A Dijkmans.   

Abstract

There is no unanimity as to whether polymyalgia rheumatica (PMR) and temporal arteritis (TA) are two distinct diseases or different features of one disease. The objective of this study was to assess the value of histological findings of temporal artery biopsy and the efficacy and complications of drug therapy as well as the frequency of malignancies. It was carried out as a retrospective follow-up study. One hundred eleven patients (89 PMR, 14 TA and 8 PMR+TA) were studied. In 56 patients with PMR a temporal artery biopsy was performed; in none of these biopsies was active arteritis found. Of the 19 patients with TA or PMR+TA, where a temporal artery biopsy was performed, arteritis was found in 15 patients. Reactivation occurred in 27 patients: 4 patients using NSAIDs and 23 patients using corticosteroids. Side effect of the medication included vertebral compression in 10 patients, most of whom were using corticosteroids. Malignancies were diagnosed in 12 of the 111 patients. Most malignancies were diagnosed long before or after the diagnosis of PMR. In case of a PMR diagnosed by the clinician a biopsy of the temporal artery has no value, while the yield of this diagnostic procedure is high in TA. Reactivation was seen quite often and warrants a prolonged period of medical treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8608683     DOI: 10.1007/bf02207931

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

Review 1.  Temporal arteritis.

Authors:  B W Goodman
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

2.  Joint imaging in polymyalgia rheumatica.

Authors:  J D O'Duffy; H W Wahner; G G Hunder
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

3.  The relation of polymyalgia rheumatica to rheumatoid arthritis.

Authors:  L A Healey; P K Sheets
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

4.  The clinical spectrum of giant cell arteritis.

Authors:  J C Mertens; J T van Dissel; R E Kibbelaar; F C Breedveld
Journal:  Neth J Med       Date:  1993-04       Impact factor: 1.422

5.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.

Authors:  K A Huston; G G Hunder; J T Lie; R H Kennedy; L R Elveback
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

6.  Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

Authors:  G Delecoeuillerie; P Joly; A Cohen de Lara; J B Paolaggi
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

8.  Prevention of blindness in giant cell arteritis by corticosteroid treatment.

Authors:  A B Myles; T Perera; M G Ridley
Journal:  Br J Rheumatol       Date:  1992-02

Review 9.  Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases.

Authors:  C M Wise; C A Agudelo; W L Chmelewski; K M McKnight
Journal:  Arthritis Rheum       Date:  1991-12

10.  [Diagnosis and prognosis of polymyalgia rheumatica and giant cell arteritis].

Authors:  J C ter Maaten; C A van de Kaa; S J Hoorntje; H F Hillen
Journal:  Ned Tijdschr Geneeskd       Date:  1991-01-12
View more
  5 in total

Review 1.  Neurology of the vasculitides and connective tissue diseases.

Authors:  P M Moore; B Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

Review 2.  Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Authors:  Thomas Nothnagl; Burkhard F Leeb
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study.

Authors:  S Deshayes; E Liozon; N Chanson; K Sacré; T Moulinet; C Blanchard-Delaunay; O Espitia; M Groh; M Versini; T Le Gallou; J-E Kahn; V Grobost; S Humbert; M Samson; R Mourot Cottet; K Mazodier; A Dartevel; J Campagne; A Dumont; B Bienvenu; M Lambert; A Daumas; D Saadoun; A Aouba; H de Boysson
Journal:  Clin Rheumatol       Date:  2019-01-07       Impact factor: 2.980

Review 4.  Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.

Authors:  Christian Dejaco; Christina Duftner; Marco A Cimmino; Bhaskar Dasgupta; Carlo Salvarani; Cynthia S Crowson; Hilal Maradit-Kremers; Andrew Hutchings; Eric L Matteson; Michael Schirmer
Journal:  Ann Rheum Dis       Date:  2010-11-19       Impact factor: 19.103

5.  Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica.

Authors:  Hyoun-Ah Kim; Jisoo Lee; You-Jung Ha; Sang-Hyon Kim; Chan-Hee Lee; Hyo-Jin Choi; Han-Joo Baek; Mie Jin Lim; Won Park; Sungiae Choi; Yeon-Sik Hong; Yoo-Hyun Lee; Bo-Ram Koh; Chang-Hee Suh
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.